- JNJ-63533054
-
- $60.00
-
2026-05-11
- CAS:1802326-66-4
- Purity: 99.88%
- Supply Ability: 10g
- JNJ 63533054
-
- $1.00
-
2019-12-24
- CAS:1802326-66-4
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 20kg
|
| | JNJ 63533054 Basic information |
| Product Name: | JNJ 63533054 | | Synonyms: | JNJ 63533054;3-Chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]benzamide;CS-2223;JNJ-63533054 (JNJ63533054;Benzamide, 3-chloro-N-[2-oxo-2-[[(1S)-1-phenylethyl]amino]ethyl]-;JNJ-63533054 >=98% (HPLC);(S)-3-Chloro-N-(2-oxo-2-((1-phenylethyl)amino)ethyl)benzamide;L-tryptophan,blood-brain,oral,CNS,L-phenylalanine,G Protein-Coupled Receptor 139,barrier,JNJ63533054,Inhibitor,GPR139,JNJ-63533054,inhibit | | CAS: | 1802326-66-4 | | MF: | C17H17ClN2O2 | | MW: | 316.78 | | EINECS: | | | Product Categories: | | | Mol File: | 1802326-66-4.mol |  |
| | JNJ 63533054 Chemical Properties |
| Boiling point | 559.7±45.0 °C(Predicted) | | density | 1.224±0.06 g/cm3(Predicted) | | storage temp. | room temp | | solubility | Soluble in DMSO (up to 35 mg/ml). | | form | powder | | pka | 12.77±0.46(Predicted) | | color | white to beige | | Optical Rotation | [α]/D -89 to -99°, c = 1 in ethanol | | Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 2 months. | | InChIKey | MWDVCHRYCKXEBY-LBPRGKRZSA-N | | SMILES | Clc1cc(ccc1)C(=O)NCC(=O)N[C@@H](C)c2ccccc2 |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral
Eye Irrit. 2
Skin Irrit. 2 |
| | JNJ 63533054 Usage And Synthesis |
| Description | JNJ-63533054 (1802326-66-4) is a potent and selective brain-penetrant GPR139 agonist (EC50=16 nM) an orphan G-protein-coupled receptor expressed in the CNS.1Tritium-labeled JNJ-63533054 binds to cell membranes expressing GPR139 and can be displaced by putative endogenous ligands.2Decreases compulsive-like alcohol drinking and hyperalgesia in alcohol-dependent rodents.3Suppresses morphine intake in a mouse self-administration model.4 | | Uses | JNJ 63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM. | | Biochem/physiol Actions | JNJ-63533054 is a potent and selective agonist of the orphan receptor hGPR139, a GPCR receptor expressed in the brain in circumventricular regions of the habenula and septum. JNJ-63533054 has an EC50 value of 16 nM, crosses the blood-brain barrier, and is orally available. | | in vivo | JNJ-63533054 (3-30 mg/kg; oral administration; once; SD rats) treatment induces a dose-dependent reduction in locomotor activity in the first hour[1].
The pharmacokinetics of JNJ-63533054 (Compound 7c; 1 mg/kg iv; 5 mg/kg po) in rat is examined. The IV clearance is 53 mL/min/kg, the Cmax is 317 ng/mL (~1 μM), the t1/2 is 2.5 hours, and JNJ-63533054 is able to cross the blood-brain barrier (BBB) with a brain to plasma ratio (b/p) of 1.2[2]. | Animal Model: | Male Sprague-Dawley rats (350-450 g)[1] | | Dosage: | 3 mg/kg, 10 mg/kg, and 30 mg/kg | | Administration: | Oral administration; once | | Result: | Induced a dose-dependent reduction in locomotor activity in the first hour.
|
| | storage | Store at RT | | References | [1] CURT A. DVORAK*. Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor[J]. ACS Medicinal Chemistry Letters, 2015, 6 9: 1015-1018. DOI:10.1021/acsmedchemlett.5b00247
[2] CHANGLU LIU. GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-Phenylalanine.[J]. Molecular Pharmacology, 2015, 88 5: 911-925. DOI:10.1124/mol.115.100412
[3] JENNI KONONOFF. Systemic and Intra-Habenular Activation of the Orphan G Protein-Coupled Receptor GPR139 Decreases Compulsive-Like Alcohol Drinking and Hyperalgesia in Alcohol-Dependent Rats.[J]. eNeuro, 2018. DOI:10.1523/eneuro.0153-18.2018
[4] DANDAN WANG. Genetic behavioral screen identifies an orphan anti-opioid system[J]. Science, 2019, 365 6459. DOI:10.1126/science.aau2078 |
| | JNJ 63533054 Preparation Products And Raw materials |
|